<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The HLA-B5 phenotype was investigated in 235 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and in 100 healthy persons </plain></SENT>
<SENT sid="1" pm="."><plain>HLA-B5 was more frequent in the patients (77 vs. 30% p &lt; 0.001, relative risk = 7.8) </plain></SENT>
<SENT sid="2" pm="."><plain>The frequency of HLA-B5 was higher in patients with <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulceration</z:e> than without (82.3 vs. 63%, p &lt; 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> showed a less frequent positivity of HLA-B5 antigen than the patients without <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> (50 vs. 79.2%, p &lt; 0.02) </plain></SENT>
<SENT sid="4" pm="."><plain>These results suggest that HLA-B5-related genes not only affect the development of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease but also the occurrence of its clinical manifestations </plain></SENT>
</text></document>